TScan Therapeutics, Inc. Common Stock TCRX
$0.78
+0.88%
at last close
Financials (TTM)
- Revenue
- $7.11 million
- Net Income
- $-117,712,000
- Net Margin
- -1655.35%
- Return on Equity
- -170.55%
- Debt-to-Equity
- 0.47
- P/E Ratio
- —
- Price / Book
- 0.76
- Price / Sales
- 7.37
Over the trailing twelve months, TScan Therapeutics, Inc. Common Stock generated revenue of $7.11 million and net income of $-117,712,000, a net margin of -1655.35%.
At the last closing price of $0.78, TCRX trades at 7.37 times sales, with a market capitalization of $52.39 million.
Key Stats
- Last Close
- $0.78
- Market Cap
- $52.39 million
- 52-Week Range
- $0.72 – $2.57
- Average Volume
- 658K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.